Lv3
289 积分 2021-03-06 加入
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
4天前
已完结
Revised Response Criteria for Malignant Lymphoma
4天前
已完结
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
12天前
已完结
Review Article: Immune Effector Cell-Mediated Enterocolitis Following CAR-T Cell Therapy-Clinical Features, Pathophysiology and Management
17天前
已完结
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
17天前
已完结
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
17天前
已完结
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma
17天前
已完结
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
17天前
已完结
Factors affecting recurrence after surgery for Crohn’s disease
17天前
已完结
Surgery in the age of biologics
17天前
已完结
皖公网安备34019202002308
